Journal Information
Vol. 37. Issue 6.
Pages 321-323 (June 2013)
Share
Download PDF
More article options
Vol. 37. Issue 6.
Pages 321-323 (June 2013)
Editorial
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
Tratamiento del cáncer de próstata y cáncer renal con fármacos orales (abiraterona y antiangiogénicos): posicionamiento de la Asociación Española de Urología
Visits
852
H. Villavicencio, C. Hernández, A. Gómez, J.M. Cózar, A. Rodríguez-Antolín, L. Prieto, M. de Cabo, J.M. Malet, J. Extramiana, J. Mata, M. Arrabal, G. Server, E. Solsona, J.I. del Valle, E. Miguélez, E. Gutiérrez, A. Elizalde, J. Mateos, J.L. Artiles, M. Jiménez-Cidre..., L.M. Nalda, N. Cruz, M. Ozonas, J. Caffaratti, M. Esteban, M. Unda, C. Reina, J.L. Álvarez-Ossorio, E. Lledó, J.C. Angulo
Ver más
Corresponding author
Junta Directiva, Asociación Española de Urología (AEU)
This item has received
Article information
These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail